Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Fusidic acid
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fusidic acid 2% cream
1310012F0AAABAB
|
Fusidic acid (Topical) | Fusidic acid | Skin | 227,328 |
|
Fusidic acid 1% modified-release eye drops
1103010H0AAAAAA
|
Fusidic acid (Eye) | Fusidic acid | Eye | 23,742 |
|
Fucidin 20mg/g cream
1310012F0BBAAAB
|
Fucidin (Topical Cream/Gel) | Fusidic acid | Skin | 10,075 |
|
Fusidic acid 250mg/5ml oral suspension
0501070M0AAAAAA
|
Fusidic acid (Systemic) | Fusidic acid | Infections | 26 |
|
Fucithalmic 1% eye drops
1103010H0BBAAAA
|
Fucithalmic | Fusidic acid | Eye | 15 |
|
Fucidin 2% gel
1310012F0BBABAC
|
Fucidin (Topical Cream/Gel) | Fusidic acid | Skin | No data available |
|
Fucidin 250mg/5ml oral suspension
0501070M0BBAAAA
|
Fucidin (Liquid) | Fusidic acid | Infections | No data available |
|
Fusidic acid 2% gel
1310012F0AAACAC
|
Fusidic acid (Topical) | Fusidic acid | Skin | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.